학술논문
Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1–2 trial
Document Type
Article
Author
Gladwin, M.T.; Gordeuk, V.R.; Desai, P.C.; Minniti, C.; Novelli, E.M.; De Castro, L.; Kato, G.J.; Morris, C.R.; Ataga, K.I.; Curtis, S.A.; El Rassi, F.; Ford, H.J.; Harrington, T.; Klings, E.S.; Lanzkron, S.; Liles, D.; Little, J.; Nero, A.; Smith, W.; Taylor, J.G.; Baptiste, A.; Hagar, W.; Kanter, J.; Kinzie, A.; Rafique, A.; Martin, T.; Telen, M.J.; Lalama, C.M.; Abebe, K.Z.
Source
In: The Lancet Haematology . (The Lancet Haematology, May 2024, 11(5):e345-e357)
Subject
Language
English
ISSN
23523026